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In anticipation of the 2012 World
Health Report, this paper was commis-
sioned to help contextualize and critically
reflect on the theme of ‘‘no health without
research.’’
Introduction
Forty years ago Archie Cochrane, in
his seminal book Effectiveness and Efficiency,
drew attention to the concentration of
health research, and particularly clinical
trials, in a very few high-income countries
[1].The situation has changed remarkably
since, but there are still many countries
where health research is virtually non-
existent. These countries have, so far,
received almost no attention in the inter-
national literature on health research and
are overlooked by funders, who feel that
they can only invest where there is suffi-
cient existing capacity to absorb resources.
We ask what might be done to help these
countries.
Clearly, a first step is to make a case for
the importance of establishing national
health research strategies. Such pro-
grammes are essential for public health
systems to function and thrive. Without
answers to core questions, such as ‘‘who is
most in need?’’ and ‘‘what do they suffer
from?’’, it is impossible to determine
‘‘which resources would help people
recover?’’ It is crucial that the scope be
‘‘national’’; missing data are frequently
imputed from neighbouring countries even
though conditions may be quite different.
Imputed data also fail to capture the
distribution of health and its determinants
within countries. Furthermore, even if
national public health authorities are able
to conduct limited surveillance among
parts of their populations, without a health
research strategy they are unlikely to be
able to capture and prepare for changes in
their citizenry’s health, whether it be a
new infectious disease or the more gradual
development of a ‘‘dual burden’’ of infec-
tious and non-communicable diseases.
Finally, without research, they cannot
know whether what they are doing is
actually working.
Which Countries Face the
Greatest Health Research
Deficits?
There is no comparable international
indicator of how much health research
various populations have access to. One
crude measure of capacity is the output of
medical research publications by research-
ers based in institutions in each country
(i.e., not research on populations by
researchers based in other countries). We
have used the SCImago database, which is
based on the SCOPUS database [2], one
of a number of bibliometric databases.
Although there is no gold standard data-
base for tracking publications [3], SCI-
mago has several important advantages for
our purposes as it covers more journals
than Web of Science (about 15,000) and
provides better coverage of publications in
languages other than English than do its
competitors and, should others wish to
extend our analyses, its method of calcu-
lating citation factors is also more inclusive
than other databases [4]. Finally, it is also
open-access, making our calculations
easy to update and highly replicable [5].
Although the per capita output of publi-
cations is a crude indicator of research
capacity, it is the only source of reasonably
comparable global data to indicate how
much health research is undertaken by
whom. Other measures, such as numbers
of researchers, are fraught with definition-
al problems [6]. Yet, although number of
publications is the best measure available,
it is important to recognise its limitations.
It does not capture quality of publications
(if such a measure exists) [7], although there
is a relatively close correlation between the
number of publications per capita from
each country and the average h-index, a
measure of both scientific productivity and
frequency of citations of researchers in each
country (r=0.61, authors’ calculations).
Nor does it distinguish the individuals being
researched, such that substantial within-
country inequalities in access to research
may be masked.
Table 1 shows the 25 countries or terri-
tories with the fewest number of indige-
nous publications in the field of medicine
over the past 15 years. Unsurprisingly,
almost all of the countries are sparsely
populated small islands. The three with
fewest published health research studies
(Cocos [Keeling] Islands, Christmas Is-
land, and Tokelau) each have fewer than
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2,000 inhabitants. There are, however,
two notable exceptions, both of which
owe their position to their self-imposed
isolation from the global community. The
Democratic Republic of Korea (North
Korea) has produced only five publica-
tions, despite being a nuclear power.
Turkmenistan, which since independence
has also been under a near-dictatorship, is
not quite as isolated commercially, given
its large-scale production of natural gas,
but its academic medical community faces
formidable barriers in engaging with the
rest of the world. In 2004, the former
president fired 15,000 public health
workers and, the following year, closed
all hospitals outside the capital as well as
all libraries, reasoning that any knowledge
his citizens required could be found either
in the Koran or a book of his own
writings, the Ruhnama. Health statistics
are believed to be routinely falsified, and
access to the Internet is extremely limited
[8].
It is important to look at publications in
relation to population size (Table 2).
Myanmar is now included in this list.
Given Myanmar’s traditionally strong
higher education sector, this suggests that
political isolation is playing a role. Many
of the countries on this list of research
deprivation fall into two broad geograph-
ical groupings: African countries and
countries of the former Soviet Union.
These two regions stand out for being
the only two in which mortality has risen
over the past several decades [9]. Others
are countries with histories of significant
conflict: Yemen, Timor-Leste, and Afgha-
nistan. The poor performance of Indone-
sia has recently been noted by the
country’s director general of health re-
search, although the proposed remedy,
involving a focus on increasing publica-
tions by students, rather than tackling
more fundamental weaknesses, has been
controversial [10].
It is also important to consider avail-
ability of resources. For those countries for
which data are available (i.e., other than
small island states, a few states engaged in
ongoing conflict, and dependent territo-
ries), there is a close correlation between
publications and gross national product
(GNP) per capita (r=0.723). However,
there is an even closer association with
total health expenditure (THE) per capita
(r=0.870), which suggests that the avail-
able economic resources are less important
than the overall priority given by govern-
ments to population health.
What Is to Be Done?
If we assume that no population should
be excluded from health research, what is
to be done? The situation in the small
island states is perhaps the easiest to address
and, indeed, this is already happen-
ing through the expansion of academic
Summary Points
N Efforts to strengthen capacity in health research have, so far, concentrated on
countries where there is existing capacity rather than those where it is almost
completely lacking.
N Judged by absolute numbers of scientific papers, those with the fewest are
mainly small islands and a few countries that are politically isolated.
N Judged by papers per capita, the lowest include countries in the former Soviet
Union and Africa, both regions experiencing declines in life expectancy in
recent years, and states experiencing conflict.
N Although there is a positive association between economic development and
research output, some relatively wealthy countries seriously underperform.
N There are many examples of good practice, including regional networks and
international partnerships.
N There is a strong argument for donors to look to the long term and consider
how best to build health research capacity where it is virtually absent.
Table 1. Countries and territories with the fewest publications in medicine (1996–
2010) in absolute numbers.
Rank Country Publications
Publications/100,000
Population
200 Mayotte 15 7.35
201 Timor-Leste 15 1.33
203 Palau 14 68.39
202 Comoros 14 1.91
205 Marshall Islands 13 24.06
204 Aruba 13 12.09
206 Virgin Islands (British) 11 40.74
208 Northern Mariana Islands 9 14.77
207 Cape Verde 9 1.81
209 Turkmenistan 8 0.16
210 Norfolk Island 7 324.83
213 United States Minor Outlying Islands 6 1904.76
211 Gibraltar 6 20.52
214 Saint Vincent and The Grenadines 6 5.49
212 Saint Lucia 6 3.45
215 Democratic Republic of Korea 5 0.02
216 Cook Islands 4 32.60
217 Kiribati 3 3.01
219 Falkland Islands (Malvinas) 2 67.68
220 Tuvalu 2 20.35
218 Anguilla 2 14.81
221 Wallis and Futuna 2 13.33
222 Cocos (Keeling) Islands 1 166.67
223 Christmas Island 1 71.28
224 Tokelau 1 70.87
Note: The term ‘‘United States Minor Outlying Islands’’ encompasses a group of Pacific atolls with no
permanent population. While featured in only six publications, it has a high proportion of scientists among
the 300 or so temporary visitors, incidentally, making it the territory with the highest number of publications
per head of population in the world.
doi:10.1371/journal.pmed.1001209.t001
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consortia. Many already participate in a
number of regional academic initiatives.
These include the University of the South
Pacific, with campuses in 11 countries, and
the University of the West Indies, with
campuses in Jamaica, Barbados, and Tri-
nidad, as well as an Open Campus that
reaches out to the remaining 13 participat-
ing countries and territories. The Caribbe-
an states also benefit from the work of the
Caribbean Epidemiology Center, based in
Trinidad. Collaborations have been facili-
tated by enhanced transport links and
especially the spread of the Internet. How-
ever, significant challenges remain. Internet
connections remain poor in some Pacific
Island states, such as Tonga, Vanuatu, and
the Solomon Islands. The University of the
South Pacific campus in Niue notes prob-
lems with ‘‘power supply, water, transpor-
tation, and absence of study facility’’ but
that its ‘‘students are very motivated to
succeed’’ [11]. These regional universities
have embraced distance learning, often
supported by part-time local tutors, and
there is at least the basic infrastructure
needed to undertake research.
Where there is a national research stra-
tegy, there may be regional and cultural
specificities that pose barriers to adopting
international scientific standards. One
example of this problem occurs in the
former Soviet countries. In 1928, Stalin
introduced what was termed ‘‘Soviet
science’’, with its adherents privileged over
those using conventional scientific meth-
ods [12]. Soviet science was characterised
by references to statements by the found-
ing fathers of the major disciplines, as well
Marx and Lenin, who were considered to
have provided the basis for all subsequent
discoveries. The most notorious example
was the work of the agronomist Trofin
Lysenko, whose rejection of Mendelian
inheritance contributed to widespread
failures of Soviet agriculture. In medicine,
a regime that was unable to develop a
modern pharmaceutical industry benefited
from the rejection of concepts such as
randomised controlled trials that would
likely have revealed problems with the
various electromagnetic and physical ther-
apies being promoted in government
hospitals [13]. The legacy of Soviet science
persists, with research still being under-
taken on, for example, the potential role of
magnets to treat hypertension (based on
the incorrect view that it is caused by
increased blood viscosity) [14], and the use
of many inappropriate mineral and vita-
min preparations to treat a wide range of
medical disorders [15,16]. Here, the task is
one of unlearning perceived wisdom.
Such challenges create a different, and
arguably more difficult, set than those that
exist where there is no existing research
support.
Another difficulty is in attracting and
maintaining expertise in settings of low
quantity and quality production of health
science. Academic staff are aging, in part
because those who would otherwise have
retired remain dependent on income from
teaching in the absence of adequate
pensions, and also because they have been
unable to recruit or retain talented youn-
ger staff. The career prospects in academia
for young researchers, especially those
who have trained in the West, are abys-
mal. Wages are several-fold lower than
what they can obtain either in Western
countries or in the private sector in their
own countries. Domestic research funding
is scarce and, in the post-Soviet countries,
its distribution is determined by a geron-
tocracy whose ideas were shaped during
the Soviet period, many of whom do not
read English and, as a consequence, are
unfamiliar with the international litera-
ture. Foreign qualifications are not recog-
nised. Indeed, the authors are aware of
how certain universities in some countries,
such as Russia, disregard papers published
in English, even when in leading interna-
tional journals, in promotion processes. A
few dedicated individuals continue to
participate in research voluntarily, often
in association with foreign collaborators,
but without any domestic institutional sup-
port. However, their activities are inevita-
bly highly constrained.
To continue with the post-Soviet exam-
ple, we can draw lessons from glimmers
of success in spite of the aforementioned
issues. Russia has recently refocused its
research strategy to support excellence and
to recruit leading international scientists,
especially but not exclusively Russians
who have previously moved abroad [17].
Georgia, despite major financial con-
straints, has already made notable prog-
ress. It has embraced a policy of openness
to international collaboration and has
established foundations that offer skilled
Table 2. Countries and territories with the fewest publications in medicine (1996–
2010) per capita.
Rank Country Publications
Publications/100,000
Population
200 Cape Verde 9 1.81
201 Kyrgyzstan 92 1.71
203 Mozambique 399 1.71
202 Niger 255 1.64
205 Mauritania 54 1.56
204 Yemen 367 1.53
206 Ethiopia 1,265 1.53
208 Sierra Leone 86 1.47
207 Kazakhstan 239 1.46
209 Timor-Leste 15 1.33
210 Guinea 113 1.13
213 Eritrea 57 1.08
211 Indonesia 1,948 0.81
214 Burundi 66 0.79
212 Uzbekistan 201 0.71
215 Liberia 27 0.68
216 Chad 51 0.45
217 Angola 84 0.44
219 Afghanistan 145 0.42
220 Tajikistan 29 0.42
218 Myanmar 192 0.40
221 Somalia 21 0.23
222 Turkmenistan 8 0.16
223 Democratic Republic Congo 87 0.13
224 Democratic Republic of Korea 5 0.02
doi:10.1371/journal.pmed.1001209.t002
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researchers, many trained abroad, a career
structure. It has emphasised the impor-
tance of being able to read English. While
accepting the limitations of the indicator
used in this paper, it is noteworthy that it
has achieved more than 50% more medi-
cal publications per 100,000 population
than Russia (16.6 versus 11.2), and five
times more than countries such as Ukraine
(3.7) and Moldova (3.6). Indeed, Georgian
public-health researchers are engaged in
projects across the former Soviet Union
[18].
The situation in Africa is challenging,
but hopeful in parts. Many of the countries
in Table 2 have suffered major conflicts in
the past 15 years, including Niger, Liberia,
Sierra Leone, Chad, Somalia, and Zim-
babwe. Some are still considered fragile
states, with weak governments struggling
to deliver even the most basic protection
for their populations. However, no African
country appears in the top 60 when
ranked by publications per 100,000 pop-
ulation. The six highest are Tunisia (72.1),
Seychelles (57.8), South Africa (41.1),
Gambia (38.5), Gabon (30.6), and the
Republic of Congo (16.7).
Some clues are apparent from a com-
parison of output with GNP and THE per
capita (Figures 1 and 2). These confirm
that having resources is not sufficient. Oil-
rich and authoritarian, Equatorial Guinea
and Libya both produce many fewer
publications than would be expected.
Seychelles and South Africa both have
well-established higher education and
medical sectors, albeit in the latter they
have suffered from limited funding for
many years. Yet, in contrast to the
Seychelles, with which it otherwise has
much in common, Mauritius does less well
than expected. Tunisia has strong links
with France, including the highly produc-
tive Institut Pasteur de Tunis [19]. Gam-
bia hosts a major tropical medicine centre
run by the United Kingdom Medical
Research Council. The Medical Research
Unit at the Albert Schweitzer Hospital in
Gabon, another good performer, has a
strong track record of project-based fund-
ing from leading international research
funders and works closely with German
researchers. The Republic of Congo also
does better than would be expected and, in
Brazzaville, the Congolese Foundation for
Medical Research recently made a signif-
icant investment in capacity development
and is collaborating actively with research-
ers in neighbouring countries. There are
also a number of regional initiatives
bringing together a number of African
countries, such as the European Commu-
nity-funded European and Developing
Countries Clinical Trials Partnership,
which includes 47 sub-Saharan African
countries [20], and the South African
National School of Public Health, which
is training graduates from neighbouring
countries [21].
It is, however, those countries with the
least capacity that we are concerned with
here. In addition to those in Table 2, there
are a further six that have fewer than three
publications per 100,000 population: Su-
dan, Lesotho, Rwanda, Madagascar, Al-
geria, and the Central African Republic.
Many of these have previously been
identified as lacking any capacity for
postgraduate training for public health;
in the same study, it was also noted how
that measure of capacity in the Franco-
phone and Lusophone countries was
especially weak, a finding confirmed here
[22]. This is likely to reflect the growing
dominance of English in the international
scientific literature [23], which will disad-
vantage those potential researchers unable
to read it, a problem shared with the
former Soviet countries.
Figure 1. Association between publication output (1996–2010) and gross national product per capita (2008), Africa.
doi:10.1371/journal.pmed.1001209.g001
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All of these countries are on different
trajectories and face different challenges.
In each case the response will vary. For
example, Rwanda, despite suffering up to
a million deaths in the violence of 1994, is
now making substantial progress in many
sectors, including health care and higher
education. This may be a country that
might benefit from additional targeted
investment in research capacity, building
on the recently created National Center
for Clinical Research, a development that
has been supported by President Kagame
[24]. However, further investment may be
linked to progress in human rights [25].
On the other hand, the governments in
Madagascar and Sudan have attracted
international condemnation for failures of
governance and human rights abuses, and
effective responses may have to await
resolution of these issues. Some other
African countries either have no function-
ing central government, such as Somalia,
or governments that have extremely lim-
ited capacity in any sector, such as Niger,
Mauritania, and the Central African
Republic. It is difficult to see what can
be done in these countries without stability
and significant strengthening of basic
governance functions. Lesotho has the
scope to strengthen its existing collabora-
tions with South Africa, such as those with
the Medical Research Council.
Then there are countries that are
politically stable and have sufficient pop-
ulation and economic resources to support
a research infrastructure, yet have so far
failed to create one. These include In-
donesia, Ethiopia, the Philippines (1.92
publications/100,000 population), and Al-
geria (2.28 publications/100,000 popula-
tion). These countries may be able to learn
from history. In the 1920s, the Rockefeller
Foundation stimulated public health train-
ing and research by major grants to create
academic centres in 21 countries, includ-
ing the United Kingdom (the London
School of Hygiene and Tropical Medi-
cine), China, Yugoslavia, Canada, and
Brazil. More recently, Atlantic Philanthro-
pies have supported schools in Vietnam
and South Africa, the Wellcome Trust has
embarked on capacity-building program-
mes in India and Africa, and the Open
Society Institute has supported public
health programmes in central and eastern
Europe [26]. Not all such developments
have been funded by Western donors; the
James P. Grant School of Public Health
was established by the Bangladesh Reha-
bilitation Assistance Committee, the coun-
try’s largest non-governmental organisation
[27]. There is now a considerable body of
experience with these initiatives. Key
lessons learnt include the need for sustained
investment (over a period of at least ten
years), support for academic leadership and
managerial skills and not just teaching and
research skills, and the creation of career
pathways for graduates [28].
Notwithstanding the current global fi-
nancial crisis, there is an argument to be
made for leading donors to explore the
scope for strategic investment in higher
education in some countries that have so far
been neglected. Obvious emerging priorities
are those countries of North Africa that are
in the process of transitioning to democratic
rule, and where research capacity has, so
far, been very limited. For example, Ethio-
pia has made substantial achievements in
health reform in the past two decades from
a very difficult starting point, and there is
now a high level of political commitment to
investing in health [29].
Finally, there are a few countries in other
parts of the world that, like some of those in
Figure 2. Association between publication output (1996–2010) and total health expenditure per capita (2008), Africa.
doi:10.1371/journal.pmed.1001209.g002
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Africa, are suffering from, or emerging
from, the effects of extensive conflict. These
include Afghanistan and Timor-Leste. In
each, as in similar countries in Africa, the
development of health research capacity
will inevitably take second stage to the
challenge of achieving peace, stability, and
national reconstruction.
Throughout this review, we have noted
the necessity of taking account of each
country’s specific circumstances. Never-
theless, at the risk of generalisation, we can
identify four broad clusters of countries,
defined according to their access to
resources and commitment to building
health research capacity, each of which
may benefit from particular measures.
These are summarised in Box 1.
Conclusions
One speaker at the 2008 Global Min-
isterial Forum on Research for Health, in
Bamako, Mali, in 2011 said ‘‘Countries
don’t need a national airline, but they do
need a national health research strategy’’.
Although there has been a steady increase
in the participation by low- and middle-
income countries in the international
research community in recent decades,
there are still many that lack anything
resembling a health research strategy. The
reasons vary. In some cases they are
political, when regimes shun international
engagement. In others they are geograph-
ical, as with small and often remote island
communities. In others still they are
historical, as in those countries that have
emerged from conflict. In some, there may
be little that can be done until there are
governments in place that value the health
of their populations and see the benefit of
investing in the knowledge needed to
address their problems. Yet, there are also
a few where there is political commitment,
and where relatively small investments in
capacity could make a difference. Each
must be considered individually. However,
one thing is certain. None should be
abandoned by the global health research
community.
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